StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Upgrades ResMed (RMD) to Overweight
January 24, 2017 7:56 AM
JPMorgan upgraded ResMed (NYSE: RMD) from Neutral to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Upgrades
Next Articles
ResMed (RMD) Tops Q2 EPS by 3c
January 23, 2017 4:08 PM
Form 8-K RESMED INC For: Jan 23
January 23, 2017 4:06 PM
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017
January 23, 2017 4:05 PM